These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effects of phenformin on peripheral glucose utilization and insulin action in obesity and diabetes mellitus. Butterfield WJ. Ann N Y Acad Sci; 1968 Mar 26; 148(3):724-33. PubMed ID: 5242146 [No Abstract] [Full Text] [Related]
5. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. J Clin Invest; 1994 Oct 26; 94(4):1543-9. PubMed ID: 7523453 [Abstract] [Full Text] [Related]
9. Long-term fat-feeding-induced insulin resistance in normal NMRI mice: postreceptor changes of liver, muscle and adipose tissue metabolism resembling those of type 2 diabetes. Hedeskov CJ, Capito K, Islin H, Hansen SE, Thams P. Acta Diabetol; 1992 Oct 26; 29(1):14-9. PubMed ID: 1520900 [Abstract] [Full Text] [Related]
11. Role of glucose transport in the postreceptor defect of non-insulin-dependent diabetes mellitus. Ciaraldi TP, Kolterman OG, Scarlett JA, Kao M, Olefsky JM. Diabetes; 1982 Nov 26; 31(11):1016-22. PubMed ID: 6757010 [No Abstract] [Full Text] [Related]
13. Insulin receptor- and nonreceptor-controlled cellular substrate processing. A review of clinical studies in the isolated human adipocyte model. Pedersen O. J Endocrinol Invest; 1985 Feb 26; 8(1):77-87. PubMed ID: 3886773 [No Abstract] [Full Text] [Related]
14. Post insulin-receptor abnormalities in insulin resistance of obese rodents: emphasis on muscle and hepatic abnormalities. Jeanrenaud B, Zaninetti D, Terrettaz J. Prog Clin Biol Res; 1982 Feb 26; 102 Pt C():251-7. PubMed ID: 7167462 [No Abstract] [Full Text] [Related]
15. [Glucocorticoid-induced diabetes]. Ogawa Y, Tomotsune K, Suda T. Nihon Rinsho; 2005 Feb 26; 63 Suppl 2():324-8. PubMed ID: 15779396 [No Abstract] [Full Text] [Related]
16. Insulin resistance in thermally-injured rats is associated with post-receptor alterations in skeletal muscle, liver and adipose tissue. Carter EA, Burks D, Fischman AJ, White M, Tompkins RG. Int J Mol Med; 2004 Oct 26; 14(4):653-8. PubMed ID: 15375597 [Abstract] [Full Text] [Related]
17. The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Randle PJ, Garland PB, Newsholme EA, Hales CN. Ann N Y Acad Sci; 1965 Oct 08; 131(1):324-33. PubMed ID: 5216972 [No Abstract] [Full Text] [Related]
18. Cellular mechanisms of insulin action: implications for insulin resistance and type II diabetes mellitus. Pershadsingh HA, Christensen RL, McDonald JM. Clin Chem; 1986 Oct 08; 32(10 Suppl):B19-27. PubMed ID: 3530537 [No Abstract] [Full Text] [Related]
19. The Banting Memorial Lecture 1971. Physiology of insulin in man. Cahill GF. Diabetes; 1971 Dec 08; 20(12):785-99. PubMed ID: 4941092 [No Abstract] [Full Text] [Related]
20. [The fundamentals of the pharmacology of antidiabetic substances]. Losert W. Pharmazie; 1975 Jul 08; 30(7):422-33. PubMed ID: 1101277 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]